Back
Citius Oncology Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
53
CTOR
Citius Oncology
Last Price:
$0.88
Seasonality Move:
112.09%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTOR is experiencing selling pressure, which indicates risk of future bearish movement.
Citius Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.87 | Sell |
20-day SMA: | 0.76 | Buy |
50-day SMA: | 0.77 | Buy |
200-day SMA: | 2.73 | Sell |
8-day EMA: | 0.84 | Buy |
20-day EMA: | 0.8 | Buy |
50-day EMA: | 0.84 | Buy |
200-day EMA: | 2.85 | Sell |
Citius Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 55.67 | Buy |
Chaikin Money Flow: | -45450 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.64 - 0.84) | Buy |
Bollinger Bands (100): | (0.74 - 1.22) | Sell |
Citius Oncology Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Citius Oncology Stock
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 0.85 while CTOR 8-day simple moving average is 0.87, which is a Sell signal.
-
The stock price of CTOR is 0.85 while Citius Oncology 20-day SMA is 0.76, which makes it a Buy.
-
Citius Oncology 50-day simple moving average is 0.77 while CTOR share price is 0.85, making it a Buy technically.
-
CTOR stock price is 0.85 and Citius Oncology 200-day simple moving average is 2.73, creating a Sell signal.
CTOR Technical Analysis vs Fundamental Analysis
Buy
53
Citius Oncology (CTOR)
is a Buy
Is Citius Oncology a Buy or a Sell?
-
Citius Oncology stock is rated a BuyThe current Citius Oncology [CTOR] share price is $0.85. The Score for CTOR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Citius Oncology Stock Info
Market Cap:
61M
Price in USD:
0.85
Share Volume:
74.2K
Citius Oncology 52-Week Range
52-Week High:
49.00
52-Week Low:
0.55
Buy
53
Citius Oncology (CTOR)
is a Buy
Citius Oncology Share Price Forecast
-
What is the Citius Oncology stock price today?The Citius Oncology stock price is 0.85 USD today.
-
Will CTOR stock go up or go down?Citius Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology is not overvalued.
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 0.85 while CTOR 8-day exponential moving average is 0.84, which is a Buy signal.
-
The stock price of CTOR is 0.85 while Citius Oncology 20-day EMA is 0.80, which makes it a Buy.
-
Citius Oncology 50-day exponential moving average is 0.84 while CTOR share price is 0.85, making it a Buy technically.
-
CTOR stock price is 0.85 and Citius Oncology 200-day simple moving average is 2.85, creating a Sell signal.
Technical Analysis of Citius Oncology
Should I short Citius Oncology stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Citius Oncology is a Buy
-
Citius Oncology Relative Strength Index (RSI) is 55.67, which suggest Citius Oncology is overbought
-
The Bollinger Bands (25) for Citius Oncology is (0.64 - 0.84), which suggest Citius Oncology is a Sell
-
The Bollinger Bands (100) for Citius Oncology is (0.74 - 1.22), which suggest Citius Oncology is a Sell
* Citius Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.